Article
The emerging problem of linezolid-resistant enterococci.
Journal of global antimicrobial resistance - 1 Jun 2018
Bi Ruru, Qin Tingting, Fan Wenting, Ma Ping, Gu Bing
Abstract excerpt
Enterococcus is a significant pathogen in numerous infections, particularly in nosocomial infections, and is thus a great challenge to clinicians. Linezolid (LNZ), an oxazolidinone antibiotic, is an important therapeutic option for infections caused by Gram-positive bacterial pathogens, especially vancomycin-resistant enterococci. A systematic review was performed of the available literature on LNZ-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
